Global News and Digital Insights
for the Healthcare Industry

Pfizer to offer refund for its new drug Panzyga

After mulling over the idea for several years, the pharma giant, Pfizer, is set to protect its patients and promote its new drug ‘Panzyga’, for the rare disorder, chronic inflammatory demyelinating polyneuropathy (CIPD), through the warranty programme.

Pfizer to offer refund for its new drug Panzyga

After mulling over the idea for several years, the pharma giant, Pfizer, is set to protect its patients and promote its new drug ‘Panzyga’, for the rare disorder, chronic inflammatory demyelinating polyneuropathy (CIPD), through the warranty programme.

Digital Health

Medical Research

AI & Robotics

Pharma

Food as Medicine

Americas Stories

EMEA Stories

APAC Stories

Subscribe Now...

Weekly Digest of Top Digital Innovations

Sign up for HealthGeniuses weekly newsletter
and stay ahead of the curve